Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for QA Approval of In-Process Controls – V 2.0

Posted on By

Tablets: SOP for QA Approval of In-Process Controls – V 2.0

Standard Operating Procedure for QA Approval of In-Process Controls

Department Tablet
SOP No. SOP/TAB/230/2025
Supersedes SOP/TAB/230/2022
Page No. Page 1 of 5
Issue Date 01/04/2026
Effective Date 06/04/2026
Review Date 01/04/2027

1. Purpose

The purpose of this SOP is to ensure that all in-process controls used in the manufacturing of tablets are approved by the Quality Assurance (QA) team. It ensures that all processes meet the required standards for consistency, quality, and regulatory compliance.

2. Scope

This SOP applies to all in-process controls implemented during the manufacturing process of tablets. It covers the procedures for establishing, reviewing, and approving in-process controls, including sampling, testing, and documentation.

3. Responsibilities

  • QA Manager: Oversees the approval process for all in-process controls to ensure compliance with GMP and regulatory standards.
  • Production Manager: Ensures that the in-process controls are applied during manufacturing and that appropriate documentation is provided for QA review.
  • Quality Control (QC) Team: Performs the testing and ensures that in-process tests meet the established specifications.
  • Regulatory Affairs Team: Ensures that the in-process controls comply with regulatory guidelines and standards.

4. Accountability

The QA Manager is accountable for ensuring that all in-process controls are reviewed and approved according to regulatory requirements. The Production Manager is responsible for implementing in-process controls and ensuring the accurate documentation of results.

5. Procedure

5.1 Establishment of In-Process Controls

  1. Identify the critical process parameters and quality attributes that require in-process controls, based on product specifications (Annexure-1).
  2. Develop in-process control protocols to monitor and control these parameters throughout the manufacturing process (Annexure-2).
  3. Ensure that the in-process controls are validated to meet the established specifications for the product (Annexure-3).
See also  Tablets: SOP for Adhesion Testing of Coated Tablets During Production - V 2.0

5.2 QA Review and Approval of In-Process Control Protocols

  1. The QA Manager reviews the in-process control protocols to ensure they align with the product’s specifications, regulatory requirements, and GMP standards (Annexure-4).
  2. The in-process control protocols must be signed and approved by the QA Manager before implementation in the manufacturing process (Annexure-5).
  3. Ensure that any changes to the in-process controls are reviewed and approved by QA before implementation (Annexure-6).

5.3 Monitoring of In-Process Controls

  1. During the manufacturing process, production personnel are responsible for applying the in-process controls as outlined in the approved protocol (Annexure-7).
  2. Ensure that production personnel document the results of in-process tests, including any deviations or non-compliance (Annexure-8).
  3. QC personnel should verify that the in-process control testing is conducted in accordance with the approved protocols (Annexure-9).

5.4 Review of In-Process Control Results

  1. QA will review the results of all in-process control tests to ensure compliance with the established specifications (Annexure-10).
  2. Any out-of-specification results must be documented, investigated, and corrective actions must be implemented (Annexure-11).
  3. QA will approve the results if they meet the specifications or take corrective action if deviations are found (Annexure-12).

5.5 Documentation and Record-Keeping

  1. Ensure that all in-process control records, including test results, deviations, and corrective actions, are documented and stored for review (Annexure-13).
  2. Ensure that all in-process control records are retained in accordance with company policy and regulatory requirements (Annexure-14).
See also  Tablets: SOP for FTIR Analysis of Excipients in Tablets - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • GMP: Good Manufacturing Practice
  • CAPA: Corrective and Preventive Action

7. Documents

  1. In-Process Control Protocols (Annexure-1)
  2. In-Process Control Validation Reports (Annexure-2)
  3. Approved In-Process Control Protocols (Annexure-3)
  4. QA Review of In-Process Control Protocols (Annexure-4)
  5. In-Process Control Approval Form (Annexure-5)
  6. In-Process Control Change Control Form (Annexure-6)
  7. In-Process Test Results Documentation (Annexure-7)
  8. In-Process Test Results Review Form (Annexure-8)
  9. QA Review of In-Process Control Results (Annexure-9)
  10. Deviation Report and Investigation (Annexure-10)
  11. In-Process Control Approval Log (Annexure-11)
  12. Corrective Action Report (Annexure-12)
  13. In-Process Control Records Retention Log (Annexure-13)
  14. In-Process Control Records Storage Log (Annexure-14)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (FDA)
  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • USP <1079> – Good Storage and Distribution Practices

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: In-Process Control Protocols

Parameter Test Method Acceptance Criteria Frequency
Tablet Weight Weight Test ±5% of target Every batch

Annexure-2: In-Process Control Validation Reports

Parameter Method Validation Result
Tablet Hardness USP Test Validated

Annexure-3: Approved In-Process Control Protocols

Protocol Approval Date Approved By
Tablet Weight Control 01/04/2026 QA Manager

Annexure-4: QA Review of In-Process Control Protocols

Protocol Name Reviewed By Review Date Approval Status
Tablet Weight Protocol John Doe 02/04/2026 Approved

Annexure-5: In-Process Control Approval Form

Parameter Approval Date Approved By
Tablet Hardness 02/04/2026 QA Manager

Annexure-6: In-Process Control Change Control Form

Change Description Reason for Change Approval Date
Frequency Change for Weight Control Process Improvement 03/04/2026

Annexure-7: In-Process Test Results Documentation

Test Name Test Result Sample Size Acceptance Criteria
Tablet Weight 4.8 grams 10 tablets ±5% of target

Annexure-8: In-Process Test Results Review Form

Reviewed By Review Date Approval Status
Jane Smith 04/04/2026 Approved

Annexure-9: QA Review of In-Process Control Results

Review Date Reviewed By Comments
04/04/2026 John Doe No issues found

Annexure-10: Deviation Report and Investigation

Deviation Investigation Corrective Action
Out-of-spec weight Investigating equipment calibration Calibrate equipment and retrain staff

Annexure-11: In-Process Control Approval Log

Parameter Approval Date Approved By
Tablet Hardness 05/04/2026 QA Manager

Annexure-12: Corrective Action Report

Action Taken Completion Date Responsible Person
Recalibration of hardness testing equipment 06/04/2026 Maintenance Manager

Annexure-13: In-Process Control Records Retention Log

Record Name Retention Period Location
Tablet Hardness Records 5 years QA Archive

Annexure-14: In-Process Control Records Storage Log

Record Type Storage Location Last Accessed
Tablet Weight Control Records Digital Archive 01/04/2026

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP creation New process QA Head
01/02/2025 2.0 Updated in-process control protocols and review process Process improvement QA Head
See also  Tablets: SOP for Moisture Content Testing in Granules and Tablets - V 2.0
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: SOP for Implementing Safety Training Programs for Warehouse Personnel – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version